YEARMED 2025
YEARMED 2025: Virtual series reviewing the year's best papers in endocrinology and diabetes. Expert-led discussions on breakthrough research with practical clinical applications. Sponsored by Lupin AjaDuo
How to use this course ?
Details of this course and links for Live Webinar
Video Presentation
Presentation (with Dr. Soumita Mandal)
Summary of Articles
Full Article: Comparison of FSH Pre‑treatment Versus Upfront hCG and FSH Regimens for Inducing Spermatogenesis in Congenital Hypogonadotropic Hypogonadism: A Pilot Study
Full Article: Macro‑Thyrotropin Syndrome: Prevalence and Clinical Profile of an Under‑Recognised Rare Entity in Thyroidology
Full article: Intraoperative Identification of Parathyroid Tissue Using the Ratio of Aspartate Transaminase to Lactate Dehydrogenase
Full Article: Fracture Prevention with Infrequent Zoledronate in Women 50 to 60 Years of Age
Video Presentation
Presentation (With Dr Dr Ipsita Ghosh)
Summary of Articles
Full Article: Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline
Full Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes
Full Article: Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension
Full Article: Aldosterone Synthase Inhibition With Lorundrostat for Uncontrolled Hypertension
Full Article: Glucagon-like Peptide-1 Receptor Agonists: New Evidence of Kidney and Cardiovascular Protection From the FLOW and SELECT Trials
Video Presentation
Presentation (With Dr. Ipsita Mishra)
Summary of Articles
Full Article: Preoperative SGLT2 Inhibitor Use and Postoperative Diabetic Ketoacidosis
Full Article: Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
Full Article: Effect of dapagliflozin on metabolic dysfunction-associated steatohepatitis: multicentre, double blind, randomised, placebo controlled trial
Full Article: Semaglutide Decreases Risk of Non-Arteritic Anterior Ischemic Optic Neuroapthy in Type 2 Diabetic Patients
Full Article: Tirzepatide in Adults With Type 1 Diabetes: A Phase 2 Randomized Placebo-Controlled Clinical Trial
Full Article: Semaglutide in Adults with Type 1 Diabetes and Obesity